USANA Health Sciences, Inc. (USNA) Director Sells $2,141,452.95 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 28,405 shares of the company’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $75.39, for a total transaction of $2,141,452.95. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

USANA Health Sciences, Inc. (USNA) traded up $0.15 during trading on Tuesday, hitting $75.55. 79,586 shares of the stock traded hands, compared to its average volume of 91,506. The company has a market capitalization of $1,810.00, a price-to-earnings ratio of 30.10 and a beta of 0.99. USANA Health Sciences, Inc. has a fifty-two week low of $52.55 and a fifty-two week high of $79.00.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $1.00 by $0.11. The business had revenue of $273.11 million during the quarter, compared to analyst estimates of $258.67 million. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.02%. The company’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.87 earnings per share. equities analysts predict that USANA Health Sciences, Inc. will post 4.25 earnings per share for the current year.

USNA has been the subject of several recent research reports. BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th. Sidoti lowered shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research report on Wednesday, January 24th. TheStreet lowered shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a research report on Tuesday, February 6th. Finally, Pivotal Research upped their price target on shares of USANA Health Sciences from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of New York Mellon Corp grew its position in USANA Health Sciences by 2.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 92,137 shares of the company’s stock valued at $5,317,000 after buying an additional 1,944 shares in the last quarter. Northern Trust Corp grew its position in USANA Health Sciences by 10.5% in the 2nd quarter. Northern Trust Corp now owns 177,630 shares of the company’s stock valued at $11,386,000 after buying an additional 16,948 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in USANA Health Sciences by 20.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 13,103 shares of the company’s stock valued at $756,000 after buying an additional 2,206 shares in the last quarter. Trust Co. of Vermont grew its position in USANA Health Sciences by 482.7% in the 3rd quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock valued at $272,000 after buying an additional 3,900 shares in the last quarter. Finally, California Public Employees Retirement System grew its position in USANA Health Sciences by 35.7% in the 3rd quarter. California Public Employees Retirement System now owns 23,739 shares of the company’s stock valued at $1,370,000 after buying an additional 6,239 shares in the last quarter. Hedge funds and other institutional investors own 44.67% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was first published by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/13/usana-health-sciences-inc-usna-director-sells-2141452-95-in-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply